Home » Topics » BioWorld

BioWorld
RSS

Phase III Clinical Trials Update: October 2013

Nov. 11, 2013

European Cancer Congress in Amsterdam: October 2013

Nov. 11, 2013

AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference: October 2013

Nov. 11, 2013

American College of Rheumatology: October 2013

Nov. 11, 2013

Phase I Clinical Trials Update: October 2013

Nov. 11, 2013

Phase II Clinical Trials Update: October 2013

Nov. 11, 2013

Week in Washington

Nov. 11, 2013

FDA Approvals In October

Nov. 11, 2013

Money Raised By Biotech Jan. 1 - Nov. 7, 2013

Nov. 11, 2013

Word on the Street

Nov. 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...